Skip to main content

Travere Therapeutics, Inc.

TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438533

In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Travere Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
9 insiders, $67.0M in total
Insiders trading
9
Net value
−$67.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Travere Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Travere Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Rote William E.Chief Research Officer98,197Sep 17, 20266
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER117,066Sep 17, 20267
Inrig JulaEVP, Head of R&D & CMO100,491Sep 17, 20268
Reed Elizabeth EChief Legal Officer and GC105,389Sep 17, 20269
Dube Eric MCHIEF EXECUTIVE OFFICER432,886Sep 17, 20268
Cline Christopher R.CHIEF FINANCIAL OFFICER87,508Sep 17, 20267
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER42,353Sep 17, 20266
Meckler Jeffrey ADirector91,500Sep 11, 20263
Lyons Gary ADirector61,500Aug 19, 20263
Coughlin TimothyDirector56,250Jun 16, 20264
Baynes Roy D.Director41,500Jun 16, 20266
Brinkley Ruth WilliamsDirector29,750May 21, 20261
Squarer RonDirector39,375May 21, 20261
Orwin John ADirector39,375May 21, 20261
Bruhn Suzanne LouiseDirector32,750May 21, 20261
Poole SandraDirector34,000May 21, 20261
Aselage SteveDirector146,919May 12, 20220
Clague LauraChief Financial Officer35,655May 12, 20220
Rosenberg Noah L.Chief Medical Officer47,614Aug 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 13, 2023 (view filing)Apr 112 daysCline Christopher R.Chief Financial OfficerSSale−47$21.49−$1.01K−0.1%51.5K after
May 12, 2023 (view filing)May 10-112 daysCalvin SandraSVP, Chief Accounting OfficerSSale−558$16.49−$9.20K−1.3%42.2K after2 lots10b5-1
May 12, 2023 (view filing)May 102 daysRote William E.Senior Vice President, R&DSSale−825$16.59−$13.7K−1.4%59.2K after10b5-1
May 12, 2023 (view filing)May 102 daysReed Elizabeth ESVP, GC & Corporate SecretarySSale−825$16.59−$13.7K−1.4%56.6K after10b5-1
May 12, 2023 (view filing)May 102 daysCline Christopher R.Chief Financial OfficerSSale−455$16.59−$7.55K−0.9%51.0K after
Sep 5, 2023 (view filing)Sep 5Same dayDube Eric MChief Executive OfficerSSale−4.46K$14.71−$65.5K−1.8%242.6K after
Sep 5, 2023 (view filing)Sep 5Same dayReed Elizabeth ESVP, GC & Corporate SecretarySSale−1.81K$14.71−$26.7K−3.0%58.1K after
Sep 5, 2023 (view filing)Sep 5Same dayRote William E.Senior Vice President, R&DSSale−1.81K$14.71−$26.7K−2.9%61.2K after
Sep 5, 2023 (view filing)Sep 5Same dayCline Christopher R.Chief Financial OfficerSSale−457$14.71−$6.72K−0.9%50.6K after
Oct 4, 2023 (view filing)Oct 31 dayHeerma PeterChief Commercial OfficerSSale−3.09K$8.25−$25.5K−3.7%80.3K after
Jan 5, 2024 (view filing)Jan 3-42 daysInrig JulaChief Medical OfficerSSale−2.51K$9.43−$23.6K−6.6%35.2K after2 lots
Jan 25, 2024 (view filing)Jan 232 daysCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−910$9.07−$8.25K−2.2%41.3K after
Jan 25, 2024 (view filing)Jan 232 daysHeerma PeterCHIEF COMMERCIAL OFFICERSSale−1.56K$9.07−$14.1K−1.9%78.7K after
Jan 25, 2024 (view filing)Jan 232 daysCline Christopher R.CHIEF FINANCIAL OFFICERSSale−853$9.07−$7.74K−1.7%49.7K after
Jan 25, 2024 (view filing)Jan 232 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−7.87K$8.96−$70.5K−3.2%234.7K after
Jan 25, 2024 (view filing)Jan 232 daysRote William E.SENIOR VICE PRESIDENT, R&DSSale−2.06K$8.96−$18.5K−3.3%60.5K after
Jan 25, 2024 (view filing)Jan 232 daysReed Elizabeth ESVP, GC & CORPORATE SECRETARYSSale−2.06K$8.96−$18.5K−3.5%56.0K after
Feb 2, 2024 (view filing)Feb 11 dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−2.82K$8.53−$24.1K−5.1%52.0K after
Feb 2, 2024 (view filing)Feb 11 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−3.82K$8.53−$32.6K−5.1%70.9K after
Feb 2, 2024 (view filing)Feb 11 dayInrig JulaCHIEF MEDICAL OFFICERSSale−2.17K$8.53−$18.5K−3.6%58.1K after
Feb 2, 2024 (view filing)Feb 11 dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−4.20K$8.53−$35.8K−4.0%99.5K after
Feb 2, 2024 (view filing)Feb 11 dayReed Elizabeth ESVP, GC & CORPORATE SECRETARYSSale−4.76K$8.71−$41.5K−5.9%76.3K after2 lots
Feb 2, 2024 (view filing)Feb 11 dayRote William E.SENIOR VICE PRESIDENT, R&DSSale−4.76K$8.71−$41.5K−5.6%80.7K after2 lots
Feb 2, 2024 (view filing)Feb 11 dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−19.1K$8.70−$166.4K−5.2%350.6K after2 lots
Apr 12, 2024 (view filing)Apr 111 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−54$6.74−$363.96−0.1%70.8K after
Sep 5, 2024 (view filing)Sep 41 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−514$9.51−$4.89K−0.7%70.3K after
Sep 9, 2024 (view filing)Sep 9Same dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−2.49K$11.52−$28.7K−3.2%74.6K after
Sep 9, 2024 (view filing)Sep 9Same dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−2.19K$11.52−$25.2K−2.0%108.0K after
Sep 9, 2024 (view filing)Sep 9Same dayInrig JulaCHIEF MEDICAL OFFICERSSale−2.19K$11.52−$25.2K−3.4%62.6K after
Sep 9, 2024 (view filing)Sep 9Same dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−21.1K$11.52−$243.4K−5.5%362.0K after10b5-1
Sep 9, 2024 (view filing)Sep 9Same dayReed Elizabeth ESVP, GC & CORPORATE SECRETARYSSale−4.39K$11.52−$50.5K−5.3%78.6K after10b5-1
Sep 9, 2024 (view filing)Sep 9Same dayRote William E.SENIOR VICE PRESIDENT, R&DSSale−4.39K$11.52−$50.5K−4.9%84.5K after10b5-1
Sep 10, 2024 (view filing)Sep 10Same dayInrig JulaCHIEF MEDICAL OFFICERSSale−684$12.98−$8.88K−1.1%61.9K after10b5-1
Sep 30, 2024 (view filing)Sep 30Same dayMeckler Jeffrey ADirectorSSale−40.0K$14.06−$562.4K−33.1%81.0K after10b5-1
Oct 4, 2024 (view filing)Oct 4Same dayLyons Gary ADirectorSSale−40.0K$14.73−$589.1K−44.0%51.0K after2 lots10b5-1
Nov 25, 2024 (view filing)Nov 25Same dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−12.1K$18.30−$221.2K−18.0%54.9K after
Dec 27, 2024 (view filing)Dec 261 dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−15.0K$17.22−$258.3K−21.5%54.9K after10b5-1
Jan 6, 2025 (view filing)Jan 3-63 daysInrig JulaCHIEF MEDICAL OFFICERSSale−2.51K$19.04−$47.7K−4.0%59.4K after2 lots10b5-1
Jan 23, 2025 (view filing)Jan 221 dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−925$18.94−$17.5K−1.7%54.0K after
Jan 23, 2025 (view filing)Jan 221 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−865$18.94−$16.4K−1.2%73.7K after
Jan 23, 2025 (view filing)Jan 221 dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−1.58K$18.94−$30.0K−1.5%106.4K after
Jan 23, 2025 (view filing)Jan 23Same dayBaynes Roy D.DirectorSSale−16.0K$20.00−$320.0K−34.0%31.0K after10b5-1
Jan 23, 2025 (view filing)Jan 221 dayReed Elizabeth ESVP, GC & CORPORATE SECRETARYSSale−2.44K$19.46−$47.4K−3.1%76.9K after10b5-1
Jan 23, 2025 (view filing)Jan 221 dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−10.7K$19.46−$208.9K−3.0%351.2K after10b5-1
Jan 23, 2025 (view filing)Jan 221 dayRote William E.SENIOR VICE PRESIDENT, R&DSSale−2.44K$19.46−$47.4K−2.8%83.2K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−3.35K$20.12−$67.4K−5.0%63.7K after
Feb 4, 2025 (view filing)Feb 31 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−5.19K$20.12−$104.5K−5.5%90.0K after
Feb 4, 2025 (view filing)Feb 31 dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−5.17K$20.12−$103.9K−4.0%122.7K after
Feb 4, 2025 (view filing)Feb 3-41 dayInrig JulaCHIEF MEDICAL OFFICERSSale−5.27K$20.12−$106.1K−5.9%84.2K after2 lots10b5-1
Feb 4, 2025 (view filing)Feb 31 dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−50.7K$20.21−$1.02M−10.5%430.5K after10b5-1